Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4295206
Max Phase: Preclinical
Molecular Formula: C41H53NO8
Molecular Weight: 687.87
Molecule Type: Small molecule
Associated Items:
ID: ALA4295206
Max Phase: Preclinical
Molecular Formula: C41H53NO8
Molecular Weight: 687.87
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C=C(C=O)[C@@H]1CC[C@]2(C(=O)OC)CC[C@]3(C)[C@H](CC[C@@H]4[C@@](C)(CC#N)[C@H](C(C)(C)C(=O)COC(=O)c5ccccc5OC(C)=O)CC[C@]43C)[C@@H]12
Standard InChI: InChI=1S/C41H53NO8/c1-25(23-43)27-15-18-41(36(47)48-8)20-19-39(6)29(34(27)41)13-14-32-38(5,21-22-42)31(16-17-40(32,39)7)37(3,4)33(45)24-49-35(46)28-11-9-10-12-30(28)50-26(2)44/h9-12,23,27,29,31-32,34H,1,13-21,24H2,2-8H3/t27-,29+,31-,32+,34+,38-,39+,40+,41-/m0/s1
Standard InChI Key: VNDDJBYSFFHVGJ-INVWGKOHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 687.87 | Molecular Weight (Monoisotopic): 687.3771 | AlogP: 7.47 | #Rotatable Bonds: 10 |
Polar Surface Area: 136.83 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 9 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 7.06 | CX LogD: 7.06 |
Aromatic Rings: 1 | Heavy Atoms: 50 | QED Weighted: 0.11 | Np Likeness Score: 1.70 |
1. Eroshenko DV, Krainova GF, Konysheva AV, Dmitriev MV, Grishko VV.. (2018) Synthesis, modification, and cytotoxic evaluation of 2,3-secotriterpenic β-ketoesters., 28 (23-24): [PMID:30340899] [10.1016/j.bmcl.2018.10.014] |
Source(1):